Purple Biotech (PPBT) Other Operating Expenses (2017 - 2021)

Purple Biotech (PPBT) posted quarterly Other Operating Expenses of $154000.0 for Q3 2021, up 13.24% quarter-over-quarter from $136000.0 in Q1 2021.

Purple Biotech (PPBT) Other Operating Expenses (2017 - 2021) Analysis & Trends

Purple Biotech (PPBT) has reported Other Operating Expenses for 4 consecutive years, with $154000.0 the latest figure, recorded in Q3 2021.

In Q3 2021, Other Operating Expenses changed N/A year-over-year to $154000.0; the TTM figure through Jun 2022 stood at $154000.0 (up 13.24% YoY), while the FY2025 annual figure was $20.4 million, up 14487.86% from the prior year.
Other Operating Expenses advanced to $154000.0 in Q3 2021 per PPBT's latest filing, from $136000.0 in the prior quarter.
Across five years, Other Operating Expenses topped out at $3.9 million in Q4 2017 and bottomed at -$743000.0 in Q4 2018.
Historically, Other Operating Expenses has averaged $650800.0 across 4 years, with a median of $136000.0 in 2021.
Annual changes were most pronounced in 2018 — Other Operating Expenses slumped 119.18% — and 2019, when it jumped 77.66%.
Purple Biotech's Other Operating Expenses stood at $3.9 million in 2017, then tumbled by 119.18% to -$743000.0 in 2018, then surged by 77.66% to -$166000.0 in 2019, then jumped by 192.77% to $154000.0 in 2021.
Business Quant data shows PPBT's Other Operating Expenses at $154000.0 in Q3 2021, $136000.0 in Q1 2021, and -$166000.0 in Q4 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn
10	Purple Biotech	133.62	133.62	-

Download Data